Europe PMC
Nothing Special   »   [go: up one dir, main page]

Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.

Author information

Affiliations

  • 1. Center for Biomedical Research, NHC Key Laboratory of Respiratory Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (H.Z., C.W., H.Y.).
      Authors
    • Zhang H 1
    • Wang CY 1
    • Yue H 1
    (3 authors)
  • 2. CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China (P.Z.).
      Authors
    • Zhou P 2
    (1 author)
  • 3. Wuhan Pulmonary Hospital, Wuhan, China (R.D.).
      Authors
    • Du R 3
    (1 author)

ORCIDs linked to this article

Annals of Internal Medicine, 01 Aug 2020, 173(4):324
https://doi.org/10.7326/l20-0895 PMID: 32805177 

This is a comment on "Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19." Ann Intern Med. 2020 Aug 18;173(4):323-324.

Abstract 

No abstract provided.

Full text links 

Read article at publisher's site: https://doi.org/10.7326/l20-0895

Citations & impact 

Impact metrics

26
Citations
Jump to Citations

Citations of article over time

Article citations

Go to all (26) article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.